All sites C00-96,D32-33,D42-43,D45-47,D76 1740 89.7 3.5 3.5 1.1 2.2
Mouth, pharynx C00-14 27 97.1 0.7 - 0.7 1.5
  Lip C00 2 100.0 - - - -
  Tongue C02 7 100.0 - - - -
  Mouth, other C03-06 7 97.1 - - 2.9 -
  Salivary glands C07-08 3 92.3 7.7 - - -
  Pharynx C01,C09-14 8 95.1 - - - 4.9
Digestive organs C15-26 289 79.8 4.2 8.8 2.3 4.8
  Oesophagus C15 11 94.4 - - 3.7 1.9
  Stomach C16 25 91.3 0.8 3.2 1.6 3.2
  Small intestine C17 8 82.1 2.6 5.1 5.1 5.1
  Colon C18 102 94.5 - 2.8 0.4 2.4
  Rectum, rectosigmoid C19-20 43 96.3 - 2.3 0.5 0.9
  Anus C21 4 100.0 - - - -
  Liver C22 22 62.0 10.2 16.7 3.7 7.4
  Gallbladder, bile ducts C23-24 12 65.0 5.0 13.3 5.0 11.7
  Pancreas C25 56 46.1 16.0 24.5 4.3 9.2
  Other digestive organs C26 7 38.2 - 23.5 17.6 20.6
Respiratory organs C30-39 135 60.3 18.6 13.6 4.3 3.2
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 3 100.0 - - - -
  Lung, trachea C33-34 127 60.1 19.3 13.8 4.4 2.4
  Mediastinum, pleura C38 2 33.3 25.0 33.3 - 8.3
Bone C40-41 2 91.7 8.3 - - -
Melanoma of the skin C43 89 100.0 - - - -
Skin, non-melanoma C44 66 99.7 - - 0.3 -
Mesothelioma C45 2 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 17 98.8 1.2 - - -
Breast C50 593 99.5 0.2 - 0.1 0.2
Female genital organs C51-58 176 93.8 1.8 2.0 0.7 1.7
  Cervix uteri C53 16 100.0 - - - -
  Corpus uteri C54 87 99.3 - 0.2 - 0.5
  Uterus, other C55,C58 2 22.2 22.2 22.2 - 33.3
  Ovary C56 47 87.3 3.8 4.7 1.3 3.0
  Other female genital C51-52,C57 25 87.9 4.0 3.2 2.4 2.4
Urinary organs C64-68 70 86.0 1.4 7.4 1.4 3.7
  Kidney C64 37 82.8 0.5 11.3 1.6 3.8
  Bladder and urinary tract2 C65-68 33 89.7 2.4 3.0 1.2 3.6
Eye C69 3 61.5 - 30.8 7.7 -
Brain, central nervous system C70-72,D32-33,D42-43 71 96.3 - 3.1 - 0.6
Thyroid gland C73 28 96.4 2.9 - 0.7 -
Other endocrine glands C74-75 2 100.0 - - - -
Illdefined or unknown C76,C80 31 59.9 13.4 14.0 4.5 8.3
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 136 81.8 8.7 0.9 1.3 7.3
  Hodgkin lymphoma C81 8 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 65 97.2 1.5 - - 1.2
  Malignant immunoproliferative diseases C88 1 75.0 25.0 - - -
  Myeloma and other plasma cell tumors C90 19 72.6 11.6 4.2 3.2 8.4
  Leukaemia C91-95 27 65.7 19.7 - 2.9 11.7
  Myelodysplastic syndromes D46 6 34.4 21.9 - 3.1 40.6
  Myeloproliferaitive neoplasms D45,D47 10 58.3 16.7 4.2 2.1 18.8
Not included above
  Carcinoma in situ of the breast D05 51 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 94 100.0 - - - -
  Borderline tumour of the ovary D39 13 90.9 - 3.0 - 6.1
  Basal cell carcinoma of the skin 571 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.